株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

低分子キナーゼ阻害剤の世界市場

Small Molecule Kinase Inhibitors

発行 Global Industry Analysts, Inc. 商品コード 912515
出版日 ページ情報 英文 111 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
低分子キナーゼ阻害剤の世界市場 Small Molecule Kinase Inhibitors
出版日: 2019年10月01日 ページ情報: 英文 111 Pages
概要

当レポートでは、世界における低分子キナーゼ阻害剤市場の概要、動向・発展への影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界市場における企業シェア
    • 世界の低分子キナーゼ阻害剤市場における企業シェアのシナリオ
  • 主要企業
  • 市場の動向と発展因子
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • 日本
    • カナダ
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
    • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋地域
    • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
    • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
    • アフリカ

第4章 競合企業

  • ACTELION PHARMACEUTICALS LTD.
  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MYERS SQUIBB COMPANY
  • CELGENE CORPORATION
  • ENZO LIFE SCIENCES
  • EXELIXIS, INC.
  • GENENTECH
  • H. LUNDBECK A/S
  • INCYTE CORPORATION
  • KAMIYA BIOMEDICAL COMPANY
  • NOVARTIS AG
  • PROMOCELL GMBH
  • タカラバイオ
  • TOCRIS BIOSCIENCE

第5章 調査資料

目次
Product Code: MCP-1723

Small Molecule Kinase Inhibitors market worldwide is projected to grow by US$37.6 Billion, driven by a compounded growth of 12.6%. Small Molecule Kinase Inhibitors, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$66.7 Billion by the year 2025, Small Molecule Kinase Inhibitors will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.5 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Small Molecule Kinase Inhibitors will reach a market size of US$3.7 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.2% over the next couple of years and add approximately US$9.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Actelion Pharmaceuticals Ltd.; AstraZeneca PLC; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Celgene Corporation; Enzo Life Sciences, Inc.; Exelixis, Inc.; Genentech, a Roche Company; H. Lundbeck A/S; Incyte Corporation; Kamiya Biomedical Company; Novartis AG; PromoCell GmbH; Takara Bio, Inc.; Tocris Bioscience

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Small Molecule Kinase Inhibitors Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Small Molecule Kinase Inhibitors Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Small Molecule Kinase Inhibitors Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Small Molecule Kinase Inhibitors Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Small Molecule Kinase Inhibitors Market Share (in %) by Company: 2019 & 2025
    • TABLE 4: United States Small Molecule Kinase Inhibitors Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 5: Small Molecule Kinase Inhibitors Market in the United States: A Historic Review in US$ Million for 2009-2017
  • JAPAN
    • TABLE 6: Japanese Market for Small Molecule Kinase Inhibitors: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 7: Small Molecule Kinase Inhibitors Market in Japan: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • CANADA
    • TABLE 8: Canadian Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 9: Canadian Small Molecule Kinase Inhibitors Historic Market Review in US$ Million: 2009-2017
  • CHINA
    • TABLE 10: Chinese Small Molecule Kinase Inhibitors Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 11: Small Molecule Kinase Inhibitors Historic Market Analysis in China in US$ Million: 2009-2017
  • EUROPE
    • Market Facts & Figures
    • European Small Molecule Kinase Inhibitors Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 12: European Small Molecule Kinase Inhibitors Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 13: Small Molecule Kinase Inhibitors Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 14: European Small Molecule Kinase Inhibitors Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 15: Small Molecule Kinase Inhibitors Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 16: French Small Molecule Kinase Inhibitors Historic Market Scenario in US$ Million: 2009-2017
  • GERMANY
    • TABLE 17: Small Molecule Kinase Inhibitors Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 18: German Small Molecule Kinase Inhibitors Historic Market Analysis in US$ Million: 2009-2017
  • ITALY
    • TABLE 19: Italian Small Molecule Kinase Inhibitors Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 20: Small Molecule Kinase Inhibitors Historic Market Analysis in Italy in US$ Million: 2009-2017
  • UNITED KINGDOM
    • TABLE 21: United Kingdom Market for Small Molecule Kinase Inhibitors: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 22: Small Molecule Kinase Inhibitors Market in the United Kingdom: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • SPAIN
    • TABLE 23: Spanish Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 24: Spanish Small Molecule Kinase Inhibitors Historic Market Review in US$ Million: 2009-2017
  • RUSSIA
    • TABLE 25: Russian Small Molecule Kinase Inhibitors Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 26: Small Molecule Kinase Inhibitors Market in Russia: A Historic Review in US$ Million for 2009-2017
  • REST OF EUROPE
    • TABLE 27: Rest of Europe Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 28: Small Molecule Kinase Inhibitors Market in Rest of Europe in US$ Million: A Historic Review for the Period 2009-2017
  • ASIA-PACIFIC
    • TABLE 29: Asia-Pacific Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 30: Small Molecule Kinase Inhibitors Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 31: Asia-Pacific Small Molecule Kinase Inhibitors Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 32: Small Molecule Kinase Inhibitors Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 33: Australian Small Molecule Kinase Inhibitors Historic Market Analysis in US$ Million: 2009-2017
  • INDIA
    • TABLE 34: Indian Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 35: Indian Small Molecule Kinase Inhibitors Historic Market Review in US$ Million: 2009-2017
  • SOUTH KOREA
    • TABLE 36: Small Molecule Kinase Inhibitors Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 37: South Korean Small Molecule Kinase Inhibitors Historic Market Analysis in US$ Million: 2009-2017
  • REST OF ASIA-PACIFIC
    • TABLE 38: Rest of Asia-Pacific Market for Small Molecule Kinase Inhibitors: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 39: Small Molecule Kinase Inhibitors Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • LATIN AMERICA
    • TABLE 40: Latin American Small Molecule Kinase Inhibitors Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 41: Small Molecule Kinase Inhibitors Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 42: Latin American Small Molecule Kinase Inhibitors Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 43: Argentinean Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 44: Small Molecule Kinase Inhibitors Market in Argentina in US$ Million: A Historic Review for the Period 2009-2017
  • BRAZIL
    • TABLE 45: Small Molecule Kinase Inhibitors Market in Brazil: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 46: Brazilian Small Molecule Kinase Inhibitors Historic Market Scenario in US$ Million: 2009-2017
  • MEXICO
    • TABLE 47: Small Molecule Kinase Inhibitors Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 48: Mexican Small Molecule Kinase Inhibitors Historic Market Analysis in US$ Million: 2009-2017
  • REST OF LATIN AMERICA
    • TABLE 49: Rest of Latin America Small Molecule Kinase Inhibitors Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 50: Small Molecule Kinase Inhibitors Market in Rest of Latin America: A Historic Review in US$ Million for 2009-2017
  • MIDDLE EAST
    • TABLE 51: The Middle East Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 52: Small Molecule Kinase Inhibitors Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 53: The Middle East Small Molecule Kinase Inhibitors Market Share Breakdown by Region/Country: 2009, 2019, and 2025
  • IRAN
    • TABLE 54: Iranian Market for Small Molecule Kinase Inhibitors: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 55: Small Molecule Kinase Inhibitors Market in Iran: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • ISRAEL
    • TABLE 56: Israeli Small Molecule Kinase Inhibitors Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 57: Small Molecule Kinase Inhibitors Market in Israel in US$ Million: A Historic Review for the Period 2009-2017
  • SAUDI ARABIA
    • TABLE 58: Saudi Arabian Small Molecule Kinase Inhibitors Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 59: Small Molecule Kinase Inhibitors Historic Market Analysis in Saudi Arabia in US$ Million: 2009-2017
  • UNITED ARAB EMIRATES
    • TABLE 60: Small Molecule Kinase Inhibitors Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 61: United Arab Emirates Small Molecule Kinase Inhibitors Historic Market Analysis in US$ Million: 2009-2017
  • REST OF MIDDLE EAST
    • TABLE 62: Small Molecule Kinase Inhibitors Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 63: Rest of Middle East Small Molecule Kinase Inhibitors Historic Market Analysis in US$ Million: 2009-2017
  • AFRICA
    • TABLE 64: African Small Molecule Kinase Inhibitors Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 65: Small Molecule Kinase Inhibitors Market in Africa: A Historic Review in US$ Million for 2009-2017

IV. COMPETITION

  • ACTELION PHARMACEUTICALS LTD.
  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MYERS SQUIBB COMPANY
  • CELGENE CORPORATION
  • ENZO LIFE SCIENCES
  • EXELIXIS, INC.
  • GENENTECH
  • H. LUNDBECK A/S
  • INCYTE CORPORATION
  • KAMIYA BIOMEDICAL COMPANY
  • NOVARTIS AG
  • PROMOCELL GMBH
  • TAKARA BIO
  • TOCRIS BIOSCIENCE

V. CURATED RESEARCH

Back to Top